Status:
UNKNOWN
Nutritional Intervention-induced Weight Loss During the Oncological Treatment of Obesity-related Breast Cancer
Lead Sponsor:
Hospital Clinico Universitario de Santiago
Collaborating Sponsors:
Hospital Arquitecto Marcide
Conditions:
Breast Cancer
Obesity
Eligibility:
FEMALE
50-70 years
Phase:
NA
Brief Summary
Obesity could become the first evitable cause of breast cancer in the near future. Due to the relatively slow rate of development in this field, greater efforts must be applied in this area. The HYPOT...
Detailed Description
Obesity itself is considered the second leading avoidable cause of cancer, after smoking (Renehan and Soerjomataram, 2016;Islami et al., 2019). The worldwide obesity epidemic has shown no signs of aba...
Eligibility Criteria
Inclusion
- Postmenopausal women
- Primary, histologically confirmed, incident breast cancer diagnostic
Exclusion
- Thyroid disorder,
- Diabetes mellitus,
- Cardiovascular disease,
- cerebrovascular disease
- Obesity induced by other endocrine disorders or drugs,
- Participation in any active weight loss program in the previous 3 months.
- Known or suspected narcotic or alcohol abuse,
- Severe depression or any other psychiatric disease,
- Severe liver failure
- Uncontrolled hypertension,
- Orthostatic hypotension,
- hydroelectrolytic or electrocardiographic alterations
- Prescription of drugs that may alter the lipid or glucose profile.
Key Trial Info
Start Date :
October 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 21 2025
Estimated Enrollment :
220 Patients enrolled
Trial Details
Trial ID
NCT06046755
Start Date
October 15 2023
End Date
December 21 2025
Last Update
September 21 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.